Project description
Safe 3D imaging system for breast tissue
Breast cancer is the second leading type of cancer in women worldwide. In 2018, 2 million new cases were recorded and over 620 000 deaths. Mass screening programmes and early diagnosis are based on mammography. However, this produces harmful side effects and false-positive results, requiring additional screenings. A new, more safe and precise method is a necessity. The EU-funded LOUISA 3D project will provide an innovative, non-invasive clinical breast imaging system using optoacoustic technology. This will produce scans at different wavelengths to visualise multiple features of the tissue, without patient discomfort. Project work will enable safe, precise detection and diagnostics of cancer and vascular diseases.
Fields of science
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1
Coordinator
E9 5EN London
United Kingdom
See on map